Immunogenicity of a third dose with mRNA-vaccines in the ChAdOx1-S/BNT162b2 vaccination regimen against SARS-CoV-2 variants. - García-Pérez J; Borobia AM; Pérez-Olmeda M; Portolés A; Castaño L; Campins-Artí M; Bertrán MJ; Bermejo M; Arribas JR; López A; Ascaso-Del-Rio A; Arana-Arri E; et al. (IScience, 2024)